Oncogenic fusion proteins are hybrid proteins that result from the fusion of two separate genes. These fusions often occur due to chromosomal translocations, which can lead to the juxtaposition of coding sequences that are not normally adjacent. This can result in the creation of a novel protein with oncogenic properties, contributing to the development and progression of cancer.
